Montelukast Amarox (Montelukast)

Montelukast works by selectively blocking the cysteinyl leukotriene receptor CysLT1. By preventing leukotrienes from binding to this receptor, it reduces bronchoconstriction, airway edema, and inflammatory cell recruitment, which together help control asthma and allergic airway inflammation.

The appropriate dose of Montelukast Amarox is determined by the prescribing healthcare professional based on the patient’s age, diagnosis, and clinical response. Dosage regimens are individualized and should follow the prescriber’s instructions without deviation.

Safety data for montelukast in pregnancy are limited, so it should only be used if the potential benefit justifies any potential risk to the fetus. During breastfeeding, caution is advised; the drug does pass into breast milk, and a healthcare provider should assess the risk‑benefit balance for the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is particularly useful for patients with aspirin‑sensitive asthma or those who prefer a once‑daily tablet, but it is generally used as an add‑on therapy rather than a sole replacement for inhaled steroids.

Montelukast Amarox should be stored at ambient temperature, below 25 °C. Keep the product in its original container, protect it from moisture, heat, and direct sunlight to maintain stability and potency throughout its shelf life.

Montelukast Amarox is taken orally, usually once daily in the evening, with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

Serious but rare risks include severe allergic reactions such as rash, angioedema, or anaphylaxis, as well as neuropsychiatric events like depression, mood swings, or suicidal thoughts. Patients should seek immediate medical attention if they experience any of these symptoms.

Montelukast Amarox is contraindicated in individuals with known hypersensitivity to montelukast or any of the tablet’s excipients. Patients with uncontrolled severe asthma should not rely on montelukast alone and must continue prescribed rescue inhalers and controller medications.